Among 6216 samples from 5774 patients in 14 glioma datasets, the overall alteration frequency of FNDC3B gene is 1.5% (71/4774); amplification, mutations, and deep deletions were the most common types of alteration. Here, FNDC3B is linked to central nervous system cancer.